These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 34427289)
1. Effects of serum irisin, neuregulin 4, and weight management on obese adolescent girls with polycystic ovary syndrome. Cao S; Hu Y Biosci Rep; 2021 Sep; 41(9):. PubMed ID: 34427289 [TBL] [Abstract][Full Text] [Related]
2. Association between circulating neuregulin 4 levels and metabolic, aterogenic, and AMH profile of polycystic ovary syndrome. Kurek Eken M; Sahin Ersoy G; Yayla Abide C; Sanverdi İ; Devranoglu B; Kutlu T; Çevik Ö J Obstet Gynaecol; 2019 Oct; 39(7):975-980. PubMed ID: 31064233 [TBL] [Abstract][Full Text] [Related]
3. Anti-Müllerian Hormone in Obese Adolescent Girls With Polycystic Ovary Syndrome. Kim JY; Tfayli H; Michaliszyn SF; Lee S; Nasr A; Arslanian S J Adolesc Health; 2017 Mar; 60(3):333-339. PubMed ID: 27998701 [TBL] [Abstract][Full Text] [Related]
4. Increased serum neuregulin 4 levels in women with polycystic ovary syndrome: A case-control study. Temur M; Calan M; Akşit M; Yılmaz Ö; Çift T; Akselim B; Dinçgez Çakmak B; Üstünyurt E Ginekol Pol; 2017; 88(10):517-522. PubMed ID: 29192411 [TBL] [Abstract][Full Text] [Related]
5. Circulating irisin and glucose-dependent insulinotropic peptide are associated with the development of polycystic ovary syndrome. Chang CL; Huang SY; Soong YK; Cheng PJ; Wang CJ; Liang IT J Clin Endocrinol Metab; 2014 Dec; 99(12):E2539-48. PubMed ID: 25029417 [TBL] [Abstract][Full Text] [Related]
6. Comparison of serum anti-Müllerian hormone levels in normal weight and overweight-obese adolescent patients with polycystic ovary syndrome. Cengiz H; Ekin M; Dagdeviren H; Yildiz Ş; Kaya C; Kanawati A Eur J Obstet Gynecol Reprod Biol; 2014 Sep; 180():46-50. PubMed ID: 25036408 [TBL] [Abstract][Full Text] [Related]
7. The Comparison of Irisin, Subfatin, and Adropin in Normal-Weight and Obese Polycystic Ovary Syndrome Patients. Majeed AA; Al-Qaisi AHJ; Ahmed WA Iran J Med Sci; 2024 Jun; 49(6):350-358. PubMed ID: 38952638 [TBL] [Abstract][Full Text] [Related]
8. Abnormal irisin level in serum and endometrium is associated with metabolic dysfunction in polycystic ovary syndrome patients. Wang W; Guo Y; Zhang X; Zheng J Clin Endocrinol (Oxf); 2018 Oct; 89(4):474-480. PubMed ID: 29972694 [TBL] [Abstract][Full Text] [Related]
9. Circulating Anti-Müllerian hormone in a cohort-study of women with severe obesity with and without polycystic ovary syndrome and the effect of a one-year weight loss intervention. Kataoka J; Larsson I; Lindgren E; Kindstrand LO; Schmidt J; Stener-Victorin E Reprod Biol Endocrinol; 2022 Oct; 20(1):153. PubMed ID: 36309748 [TBL] [Abstract][Full Text] [Related]
18. Irisin as a mediator between obesity and vascular inflammation in Chinese children and adolescents. Yin C; Hu W; Wang M; Lv W; Jia T; Xiao Y Nutr Metab Cardiovasc Dis; 2020 Feb; 30(2):320-329. PubMed ID: 31740239 [TBL] [Abstract][Full Text] [Related]
19. The proportion of cleaved anti-Müllerian hormone is higher in serum but not follicular fluid of obese women independently of polycystic ovary syndrome. Peigné M; Pigny P; Pankhurst MW; Drumez E; Loyens A; Dewailly D; Catteau-Jonard S; Giacobini P Reprod Biomed Online; 2020 Dec; 41(6):1112-1121. PubMed ID: 33046375 [TBL] [Abstract][Full Text] [Related]
20. Elevated circulating levels of irisin and the effect of metformin treatment in women with polycystic ovary syndrome. Li M; Yang M; Zhou X; Fang X; Hu W; Zhu W; Wang C; Liu D; Li S; Liu H; Yang G; Li L J Clin Endocrinol Metab; 2015 Apr; 100(4):1485-93. PubMed ID: 25675380 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]